TFX Stock Summary and Trading Ideas (Teleflex | NYSE:TFX)

Teleflex is a Wayne, Pennsylvania-based manufacturer of hospital supplies and medical devices primarily in the bloodstream/vascular and surgical areas. The firm reports results across seven segments: vascular access (24% of 2024 sales), interventional (19%), anesthesia (13%), surgical (15%), interventional urology (11%), original-equipment manufacturing (11%), and other (7%). Geographic exposure for the business is primarily in the US, which accounts for 60% of revenue, with international markets making up the remainder.

Teleflex trades on the NYSE stock market under the symbol TFX.

As of February 13, 2026, TFX stock price declined to $103.75 with 624,306 million shares trading.

TFX has a beta of 0.60, meaning it tends to be less sensitive to market movements. TFX has a correlation of 0.06 to the broad based SPY ETF.

TFX has a market cap of $4.59 billion. This is considered a Mid Cap stock.

Last quarter Teleflex reported $913 million in Revenue and $3.67 earnings per share. This beat revenue expectation by $20 million and exceeded earnings estimates by $.29.

In the last 3 years, TFX traded as high as $276.43 and as low as $100.18.

The top ETF exchange traded funds that TFX belongs to (by Net Assets): IJR, VTI, VB, VBR, VXF.

TFX has underperformed the market in the last year with a return of -37.3%, while the SPY ETF gained +13.0%. In the last 3 month period, TFX fell short of the market, returning -4.6%, while SPY returned +1.7%. However, in the most recent 2 weeks TFX has outperformed the stock market by returning -0.6%, while SPY returned -1.5%.

TFX support price is $102.57 and resistance is $106.52 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that TFX shares will trade within this expected range on the day.